IS5251A - 9-oxím erýþrómýsín afleiður - Google Patents

9-oxím erýþrómýsín afleiður

Info

Publication number
IS5251A
IS5251A IS5251A IS5251A IS5251A IS 5251 A IS5251 A IS 5251A IS 5251 A IS5251 A IS 5251A IS 5251 A IS5251 A IS 5251A IS 5251 A IS5251 A IS 5251A
Authority
IS
Iceland
Prior art keywords
erythromycin derivatives
oxime erythromycin
oxime
derivatives
erythromycin
Prior art date
Application number
IS5251A
Other languages
English (en)
Inventor
Wu Yong-Jin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5251A publication Critical patent/IS5251A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IS5251A 1997-06-11 1999-11-16 9-oxím erýþrómýsín afleiður IS5251A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11
PCT/IB1998/000741 WO1998056800A1 (en) 1997-06-11 1998-05-15 9-oxime erythromycin derivatives

Publications (1)

Publication Number Publication Date
IS5251A true IS5251A (is) 1999-11-16

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5251A IS5251A (is) 1997-06-11 1999-11-16 9-oxím erýþrómýsín afleiður

Country Status (31)

Country Link
EP (1) EP0988308A1 (is)
JP (1) JP2000513026A (is)
KR (1) KR20010013660A (is)
CN (1) CN1259135A (is)
AP (1) AP9801253A0 (is)
AR (1) AR012244A1 (is)
AU (1) AU7226798A (is)
BG (1) BG103947A (is)
BR (1) BR9810021A (is)
CA (1) CA2293335A1 (is)
CO (1) CO4940506A1 (is)
CZ (1) CZ9904388A3 (is)
EA (1) EA199901016A1 (is)
GT (1) GT199800074A (is)
HN (1) HN1998000073A (is)
HR (1) HRP980316A2 (is)
HU (1) HUP0002252A3 (is)
ID (1) ID24529A (is)
IL (1) IL132767A0 (is)
IS (1) IS5251A (is)
MA (1) MA26505A1 (is)
NO (1) NO996108L (is)
OA (1) OA11225A (is)
PA (1) PA8451801A1 (is)
PE (1) PE79899A1 (is)
PL (1) PL337606A1 (is)
TN (1) TNSN98083A1 (is)
TR (1) TR199902995T2 (is)
TW (1) TW448174B (is)
WO (1) WO1998056800A1 (is)
ZA (1) ZA985018B (is)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
AU5299499A (en) 1998-09-22 2000-04-10 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
AU775637B2 (en) * 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
TR200103395T2 (tr) 1999-05-24 2002-04-22 Pfizer Products Inc. 13-metil eritromisin türevleri.
CA2378671C (en) * 1999-06-07 2007-04-24 Abbott Laboratories 6-o-carbamate ketolide derivatives
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
EP3738591A3 (en) 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Novel antibacterial agents
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
DK2358379T3 (en) 2008-10-24 2016-03-07 Cempra Pharmaceuticals Inc BIOFORSVAR USING TRIAZOLHOLDIGE macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
BR112012023950A2 (pt) 2010-03-22 2016-07-05 Cempra Pharmaceuticals Inc formas cristalinas de um macrolídeo, e usos dos mesmos
PL2571506T3 (pl) 2010-05-20 2017-10-31 Cempra Pharmaceuticals Inc Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
MX2014011537A (es) 2012-03-27 2015-02-10 Cempra Pharmaceuticals Inc Formulaciones parenterales para la administracion de antibioticos macrolidos.
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
BR112015023670A2 (pt) 2013-03-15 2017-07-18 Cempra Pharmaceuticals Inc processo para preparar um composto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
TNSN98083A1 (fr) 2005-03-15
JP2000513026A (ja) 2000-10-03
AU7226798A (en) 1998-12-30
OA11225A (en) 2003-07-17
PA8451801A1 (es) 2000-05-24
CA2293335A1 (en) 1998-12-17
HN1998000073A (es) 1999-01-08
KR20010013660A (ko) 2001-02-26
BR9810021A (pt) 2000-09-19
EP0988308A1 (en) 2000-03-29
AP9801253A0 (en) 1999-12-04
NO996108D0 (no) 1999-12-10
PE79899A1 (es) 1999-08-25
PL337606A1 (en) 2000-08-28
EA199901016A1 (ru) 2000-06-26
HUP0002252A2 (hu) 2000-12-28
GT199800074A (es) 1999-11-27
AR012244A1 (es) 2000-09-27
TR199902995T2 (xx) 2000-02-21
CO4940506A1 (es) 2000-07-24
HUP0002252A3 (en) 2002-01-28
ID24529A (id) 2000-07-20
TW448174B (en) 2001-08-01
CZ9904388A3 (cs) 2002-10-16
ZA985018B (en) 1999-12-10
HRP980316A2 (en) 1999-04-30
CN1259135A (zh) 2000-07-05
BG103947A (en) 2000-07-31
WO1998056800A1 (en) 1998-12-17
NO996108L (no) 2000-02-10
IL132767A0 (en) 2001-03-19
MA26505A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
IS5251A (is) 9-oxím erýþrómýsín afleiður
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
ATE377018T1 (de) Erythromycinderivate
IS5528A (is) Ný makrólíð
NO993876D0 (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
DE69919769D1 (de) 3,6-Ketal-Makrolidantibiotika
NO20015172D0 (no) 1-Metyl-erytromycin-derivater
IS5919A (is) Ný makrólíð sýklalyf
DK1027362T3 (da) 2-halogen-6-O-substituerede ketolidderivater
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
NO980016D0 (no) Makrolider
EP1167375A4 (en) ERYTHROMYCIN DERIVATIVES
LV11898A (lv) Eritromicina atvasinajumi
EP0766685A4 (en) ARYL, ALKYL, ALKENYL AND ALKINYL MACROLID
ZA983902B (en) Erythromycin derivatives.
EP1044985A4 (en) ERYTHROMYCIN
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina
GB9700702D0 (en) Erythromycin derivatives
ZA989845B (en) 2-halo-6-O-substituted ketolide derivatives
SI1027362T1 (sl) 2-halo-6-O-substituirani derivati ketolidov